Clinical Trials Directory

Trials / Completed

CompletedNCT00758420

Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence

A Randomized, Single Blind, Placebo Controlled, Multicenter Study to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for the Treatment of Symptomatic, Visible Varicose Veins With Saphenofemoral Junction (SFJ) Incompetence.

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
77 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness of polidocanol injectable foam in the relief of symptoms, improvement of appearance, and overall effectiveness and safety in the treatment of varicose veins compared to placebo.

Detailed description

The purpose of this study is to evaluate the efficacy of polidocanol injectable foam vs placebo treatments in relief of symptoms using two disease specific questionnaires, establishment of a minimally important difference (MID) for the questionnaires, improvement in the appearance of visible varicosities by a patient and medical assessments aided by pre and post treatment photographs, and a central independent assessor evaluating pre and post treatment photographs. In addition, the study will evaluate the efficacy of polidocanol injectable foam vs the placebo treatment in the elimination of SFJ reflux or occlusion of the treated vein, and to determine whether the placebo procedure blinds the patient to treatment assignment.

Conditions

Interventions

TypeNameDescription
DRUGVarisolve (Polidocanol Endovenous Microfoam)1% polidocanol, up to 15 mL, one treatment session (initially up to 30 ml, reduced to up to 15 ml in Amendment #2)
DRUGAgitated Saline10 u/mL normal heparinized saline solution, up to 20 mL, one treatment session

Timeline

Start date
2008-10-01
Primary completion
2009-07-01
Completion
2009-08-01
First posted
2008-09-25
Last updated
2021-04-21
Results posted
2014-03-24

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00758420. Inclusion in this directory is not an endorsement.